Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

HISTORICAL FACTS: Schrodinger | History Defined

Schrodinger Stock Has Technical Strength as It Hits New 2-Year Highs

Schrodinger (SDGR) is trading at new 2-year highs. SDGR maintains strong technical momentum with shares up more than 50% over the past year. SDGR maintains a 100% “Buy” technical opinion from Barchart. Analyst sentiment is mixed, with price targets from $17 to $41.17 and high short interest (15.02%). Caution is...

Barchart · Sep 23

Why DataMEDS’ Acquisition Does Not Seem to Be Very Bullish for MEDS Stock at This Point

The low purchase price of Helomics and low revenue suggest that the acquisition is not that promising for DataMEDS AI.

Barchart · Sep 18

Great new music you need to hear from Chimpan A, Whispers Of Granite, Leoni Jane Kennedy in Prog's new Tracks Of The Week!

Cool new proggy sounds from Psychonaut, Reubes, Quadvium and more in Prog's Tracks Of The Week...

Louder · Jun 13, 2025

From analysis to the latest developments in health,
read the most diverse news in one place.

Cool new proggy sounds from Jakko Jakszyk, We Lost The Sea, Raphael Weinroth-Browne and more in Prog's new Tracks Of The Week!

Great new music you need to hear from Gwenno, Wytch Hazel, Rocking Horse Music Club, Schrodinger and more in Prog's Tracks Of The Week...

Louder · Jun 6, 2025

A Look Ahead: Phreesia's Earnings Forecast

Phreesia (NYSE:PHR) will release its quarterly earnings report on Monday, 2024-12-09. Here's a brief overview for investors ahead of the announcement.

Benzinga · Dec 6, 2024

6 Under-the-Radar AI Stocks That Analysts Expect to Rally

Morgan Stanley is betting on these stocks to benefit from the AI megatrend.

Barchart · Apr 10, 2024

3 AI-Driven Drug Stocks to Buy Before They Breakout

The pharma sector is expected to undergo a huge disruption, thanks to the impact of artificial intelligence. Here are three companies that Wall Street analysts think could benefit, based on their AI-driven R&D.

Barchart · Feb 29, 2024

Read news from The Economist, FT, and more,
with one subscription

Recap: Schrodinger Q1 Earnings

Schrodinger (NASDAQ:SDGR) reported its Q1 earnings results on Wednesday, May 4, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Schrodinger beat estimated earnings by 7.69%, reporting an EPS of $-0.48 versus an estimate of $-0.52.

Benzinga · May 4, 2022

Schrodinger: Q4 Earnings Insights

Schrodinger (NASDAQ:SDGR) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Benzinga · Feb 24, 2022

Preview: Schrodinger's Earnings

Schrodinger (NASDAQ:SDGR) is set to give its latest quarterly earnings report on Thursday, 2022-02-24. Here's what investors need to know before the announcement. Analysts estimate that Schrodinger will report an earnings per share (EPS) of $-0.39.

Benzinga · Feb 23, 2022

Why Jim Cramer Recommends Selling AGNC Investment

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Schrodinger Inc (NYSE: SDGR) is fantastic, when things are good. "When things are bad, it’s real bad. Right now, maybe go slightly. Take a small position if you want to," he added.

Benzinga · Jan 26, 2022

Coverage From

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Recursion Pharmaceuticals

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

7,923 stories

Places

United States

424,052 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.